#CMT# # / CMT# Cosmetic use of at least one probiotic microorganism (I), including Lactobacillus spp.for treating and / or preventing damage of radiance of the skin, is claimed. #CMT#ACTIVITY : # / CMT# Dermatological; Anabolic. #CMT#MECHANISM OF ACTION : # / CMT# None given. #CMT#USE : # / CMT# (I) is useful: for treating and / or preventing the damage of radiance of the skin; to prevent and / or treat loss of radiance of the skin; to confer the light skin complexion; for the prevention and / or treatment of fuzzy, dull and / or inhomogeneous skin; and for preventing and / or treating imperfection of skin, preferably pimples, sores, discolorations, liver spots, blackheads and / or melasma (all claimed). The composition is useful as food composition for human consumption such as complete nutritional drinks, mineral waters, soups, dietary supplements and food substitutes, nutritional bars, confectionery products made from fermented or not fermented milk, yogurt, milk powder, nutrition product, compositions for children and / or infants, products based on (non)fermented grain, ice cream, chocolate, coffee, culinary products such as mayonnaise, tomato puree or salad dressings product; and for animal including domestic animals such as cats and dogs; for cosmetic makeup of the skin and / or mucous membranes; in the form of e.g. foundation, a blusher, a makeup blush or eye shadow, concealer, lipstick or lips gloss; to correct the color of skin; in cosmetics and / or dermatology; to treat skin imperfections; and for improving the appearance of the skin. Tests details are described but no results given. #CMT#ADVANTAGE : # / CMT# (I): has improved moisturizing property and good care property; enhances the properties and functions of the skin barrier; restores and maintains the hydration function of the skin; and promotes the integrity of the skin and maintains its luster. #CMT#BIOLOGY : # / CMT# Preferred Components: (I) is implemented in a living form, semi activated, inactivated or dead. (I) is implemented in the form of a lysate. (I) is Lactobacillus sp., Bifidobacterium sp., Cocci, yeast, and / or spore-forming bacteria. (I) is Lactobacillus paracasei, preferably Lactobacillus paracaseiCNCM I-2116 (ST11). (I) is present at 0.0001-30 (preferably 1-5) wt.% of the composition. (I) is implemented in association with an additional active ingredient. #CMT#ADMINISTRATION : # / CMT# Administration of (I) is oral (preferred) (10 3>-10 1> 5>(preferably 10 7>-10 1> 2>) colony forming unit / g) or topical (claimed).